Scinai Immunotherapeutics announced that its subsidiary, Scinai Biopharma Services, has signed a $5.1 million development and clinical manufacturing agreement with a Nasdaq-listed U.S. biopharmaceutical company. Committed customer orders have surged to approximately $7.6 million, a 300% increase from $1.9 million at the end of 2025. This deal supports development activities in 2026 and clinical manufacturing planned for 2027, with potential additional manufacturing services valued at $5.85 million for late 2027 through mid-2028. This expansion highlights Scinai's growing contract development and manufacturing organization (CDMO) business alongside its immunology-focused therapeutic platform.
Scinai Immunotherapeutics' recent business expansion is presented here with Pluang's Health-sector market data as of Oct 13, 2026, 18:02 WIB. Of 128 priced Health-sector US stocks tradable on Pluang, 78 rose and 41 fell today. Notable movers include LFST at USD 12.69 with a 1-day change of +1.68%, NBIX at USD 139.05 with a 1-day change of -1.64% and 100% sell order activity, and SNY at USD 40.37 with a 1-day change of +1.59% and 74% buy order activity.
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
TSMC's preliminary Q3 2026 revenue reached approximately NT$1.49 trillion, about 50% higher year-over-year and above management guidance, driven by strong AI chip demand. The company holds a dominant 73% share of the global pure-play foundry market, ...
Inc. and SurveyMonkey have launched Growth Signals, a new initiative to regularly poll entrepreneurs and business leaders of fast-growing companies. This program aims to capture their priorities, challenges, and growth outlook to inform Inc.'s editor...
BNB Standard Corporation has launched a new corporate website featuring an expanded treasury dashboard that updates its Adjusted Net Asset Value and other key financial metrics intraday. This move aims to increase transparency and accountability in t...
